The growing uptake of biopharmaceuticals is expected to drive United States active pharmaceutical ingredient market through 2026 According to TechSci Research report, “United States Active Pharmaceutical Ingredient Market By Method of Synthesis (Biological v/s. Synthetic), By Source (In-house v/s Contract Manufacturing Organizations), By Distribution Channel (Online v/s Offline), By Therapeutic Application (Cardiovascular Disease, Anti-diabetic, Oncology, Neurological Disorders,